 COPENHAGEN, Denmark, March 10, 2021 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq: ASND, a biopharmaceutical company that utilizes its innovative TransConTM technologies to address unmet medical needs, today announced seven presentations at ENDO 2021, the Endocrine Societys annual meeting, taking place virtually from March 20-23, 2021. 